THE Therapeutic Goods Administration has updated its Prescribing Medicines in Pregnancy database to include new entries for cerliponase alfa (pregnancy category B2), durvalumab (category D) and safinamide (as mesilate) (category B3).
There are also amended entries for chlorpromazine (category changed from C to D), estradiol (changed from B1 to B3) and sodium valproate (valrpoic acid) with an additional safety statement updated.
The above article was sent to subscribers in Pharmacy Daily's issue from 20 Dec 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 20 Dec 18